NEULAND LAB LTD. (NEULANDLAB)

NSE: ₹16,860.00
BSE: ₹16,867.05
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Intimation about Schedule of Analyst / Institutional Investor Meeting on June 11, 2026

2026-06-05 10:06:59
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Intimation about Schedule of Analyst / Institutional Investor Meeting on June 8 & 9, 2026

2026-06-03 15:00:02
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Intimation about Schedule of Analyst / Institutional Investor Meeting on June 5, 2026

2026-05-31 19:14:46
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Intimation about Schedule of Analyst / Institutional Investor Meeting on May 28, 2026

2026-05-22 16:35:02
Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of the Earnings Call conducted on May 12, 2026

2026-05-16 16:12:48
2026-05-15 13:45:45
2026-05-13 09:32:47
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Audio Recording of the Earnings call conducted on May 12, 2026

2026-05-12 19:46:19
2026-05-12 19:16:04
Announcement under Regulation 30 (LODR)-Dividend Updates

Recommendation of final dividend for the financial year 2025-26

2026-05-12 18:02:59

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 362.99 417.75 392.83 385.01 439.60 310.84 398.03 328.36 292.75 514.27 439.71 776.25
YOY Revenue Growth % 64.12% 42.23% 45.9% -5.42% 21.1% -25.59% 1.32% -14.71% -33.41% 65.44% 10.47% 136.4%
Other Income 2.04 3.05 2.10 5.36 4.81 4.33 3.91 7.46 7.86 1.80 8.05 12.46
Total Income 365.03 420.80 394.93 390.37 444.41 315.18 401.94 335.82 300.61 516.07 447.76 788.71
Total Expenses + 281.87 299.20 290.45 298.16 335.19 265.75 329.95 296.52 283.04 386.64 393.29 501.21
Cost of Materials Consumed 164.86 139.13 153.45 174.98 154.95 133.17 145.44 141.24 161.48 227.64 199.86 230.79
Employee Benefit Expense 59.89 68.96 65.73 62.49 73.14 63.07 69.34 66.46 73.47 80.37 88.83 98.47
Other Expenses 60.56 59.40 63.60 78.09 66.22 68.08 75.71 83.93 71.25 94.75 84.69 101.16
Operating Profit 81.12 118.55 102.38 86.85 104.41 45.09 68.08 31.84 9.71 127.64 46.42 275.04
OPM % 22.3% 28.4% 26.1% 22.6% 23.8% 14.5% 17.1% 9.7% 3.3% 24.8% 10.6% 35.4%
Profit Before Tax + 83.16 121.59 104.48 92.20 129.84 49.42 127.76 39.30 17.57 129.44 54.48 287.49
Tax Expense 21.28 32.35 23.09 24.64 31.97 16.58 26.18 11.49 3.67 32.58 13.90 74.82
Tax % 25.6% 26.6% 22.1% 26.7% 24.6% 33.5% 20.5% 29.2% 20.9% 25.2% 25.5% 26%
Profit After Tax 61.88 89.25 81.39 67.56 97.87 32.84 101.59 27.81 13.90 96.85 40.57 212.67
EPS (Basic) 48.23 69.56 63.44 52.66 76.28 25.60 79.18 21.67 10.83 75.49 31.62 165.76

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 2,022.99 1,476.84 1,558.58 1,191.20 951.08 936.91 762.71
YOY Revenue Growth % 36.98% -5.24% 30.84% 25.25% 1.51% 22.84% -
Other Income 30.17 20.51 12.54 9.75 2.08 16.10 3.89
Total Income 2,053.15 1,497.35 1,571.12 1,200.95 953.15 953.01 766.60
Total Expenses + 1,564.17 1,227.42 1,169.69 985.20 870.99 847.67 671.98
Cost of Materials Consumed 819.76 574.81 632.43 487.74 437.55 439.66 391.36
Employee Benefit Expense 341.14 272.00 257.06 201.79 182.47 149.74 123.56
Other Expenses 351.84 293.93 261.65 239.34 203.84 201.94 157.07
Operating Profit 458.81 249.42 388.89 206.00 80.09 89.24 90.73
OPM % 22.7% 16.9% 25% 17.3% 8.4% 9.5% 11.9%
Profit Before Exceptional 488.98 269.93 401.44 215.75 82.16 105.33 52.92
Exceptional Items 0.00 76.40 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 488.98 346.33 401.44 215.75 82.16 105.33 52.92
Tax Expense 124.98 86.22 101.36 52.23 18.34 24.70 36.71
Tax % 25.6% 24.9% 25.2% 24.2% 22.3% 23.5% 69.4%
Profit After Tax 364.00 260.11 300.08 163.52 63.82 80.63 16.21
EPS (Basic) 283.71 202.74 233.89 127.45 49.74 62.85 12.63

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 1,447.01 1,040.38 911.48 818.87 800.71 775.20 0.00
Property, Plant & Equipment 892.29 673.71 522.72 457.43 457.12 401.73 0.00
Capital Work in Progress 209.50 44.55 45.89 40.57 20.46 17.25 0.00
Non-Current Investments 1.98 1.53 1.28 0.52 0.50 0.00 0.00
Goodwill 279.46 279.46 279.46 279.46 279.46 279.46 0.00
Other Intangible Assets 5.18 1.74 2.46 1.30 2.12 3.50 0.00
Current Assets + 1,483.13 1,139.50 921.08 760.89 582.78 549.59 0.00
Inventories 510.29 385.76 350.42 279.23 265.21 247.61 0.00
Trade Receivables 541.35 315.72 373.53 361.77 234.33 217.73 0.00
Cash and Cash Equivalents 76.67 131.93 87.58 45.42 5.09 2.44 0.00
Current Investments 0.00 107.68 0.00 0.00 3.38 6.46 0.00
LIABILITIES & EQUITY
Total Equity 1,874.47 1,524.81 1,282.70 994.10 840.50 786.46 0.00
Equity Share Capital 12.90 12.90 12.90 12.90 12.90 12.90 0.00
Other Equity 1,861.57 1,511.91 1,269.80 981.20 827.60 773.56 0.00
Non-Current Liabilities 345.47 189.39 122.17 146.71 179.83 169.82 0.00
Current Liabilities 710.20 465.69 427.68 438.96 363.16 368.51 0.00
Total Liabilities 1,055.66 655.08 549.86 585.67 542.99 538.33 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 346.68 317.38 261.18 237.21 58.58 189.36 0.00
Cash from Investing Activities -423.73 -298.16 -149.69 -61.50 -93.71 -84.42 0.00
Cash from Financing Activities 20.98 24.96 -69.28 -135.80 37.72 -113.66 0.00
Net Increase/Decrease in Cash -55.26 44.35 42.21 39.92 2.66 -8.72 0.00